T. Rowe Price Investment Management
BSX icon

T. Rowe Price Investment Management’s Boston Scientific BSX Stock Holding History

T. Rowe Price Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,745
Closed -$298K – 758
2026
Q1 		$298K Buy
+4,745
New +$380K ﹤0.01% 640

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

T. Rowe Price Investment Management's BSX Position: Q2 2026 in Review

T. Rowe Price Investment Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,745 shares — an estimated $298K sold.

T. Rowe Price Investment Management first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $298K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • T. Rowe Price Investment Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 4,745 Boston Scientific shares in Q2 2026, an estimated $298K.
  • T. Rowe Price Investment Management first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
  • T. Rowe Price Investment Management's Boston Scientific position peaked at $298K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.